1. Home
  2. GRI vs EDBL Comparison

GRI vs EDBL Comparison

Compare GRI & EDBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GRI Bio Inc.

GRI

GRI Bio Inc.

HOLD

Current Price

$2.49

Market Cap

1.9M

Sector

Health Care

ML Signal

HOLD

Logo Edible Garden AG Incorporated

EDBL

Edible Garden AG Incorporated

HOLD

Current Price

$3.05

Market Cap

1.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRI
EDBL
Founded
2018
2020
Country
United States
United States
Employees
N/A
99
Industry
Biotechnology: Pharmaceutical Preparations
Farming/Seeds/Milling
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
1.9M
1.8M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
GRI
EDBL
Price
$2.49
$3.05
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$644.00
N/A
AVG Volume (30 Days)
338.7K
183.3K
Earning Date
05-14-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$29.56
Revenue Next Year
N/A
$20.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.18
$0.15
52 Week High
$11.12
$7.54

Technical Indicators

Market Signals
Indicator
GRI
EDBL
Relative Strength Index (RSI) 53.72 59.22
Support Level $1.21 $2.49
Resistance Level $2.87 $4.15
Average True Range (ATR) 0.23 0.37
MACD -0.09 -0.09
Stochastic Oscillator 52.73 8.11

Price Performance

Historical Comparison
GRI
EDBL

About GRI GRI Bio Inc.

GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.

About EDBL Edible Garden AG Incorporated

Edible Garden AG Inc is a next-generation controlled environment agriculture farming company. It uses traditional agricultural growing techniques together with technology to grow fresh, organic food, sustainably and safely while improving traceability. The company uses the controlled environment of traditional greenhouse structures, such as glass greenhouses together with hydroponic and vertical greenhouses to sustainably grow organic herbs and lettuces.

Share on Social Networks: